Column GROUP Gp, L.P., 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 302,536 shares at $13.47 ($4.1M) on 2022-05-31, disclosed to the SEC on 2022-06-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.47 | 2,040 | $27K | 0.7% |
| 2 | $13.47 | 59,766 | $805K | 19.8% |
| 3 | $13.47 | 59,766 | $805K | 19.8% |
| 4 | $13.45 | 3,036 | $41K | 1.0% |
| 5 | $13.45 | 88,964 | $1.2M | 29.4% |
| 6 | $13.45 | 88,964 |
| $1.2M |
| 29.4% |
| Total | $13.46 avg | 302,536 | $4.1M | 100% |
| Filing → |
| NGM | BUY | 2022-05-11 | $2.5M | — | Filing → |
| NGM | BUY | 2019-11-13 | $180 | — | Filing → |
| CNST | BUY | 2019-10-07 | $12.0M | — | Filing → |